Safety of Ticagrelor+ Warfarin in Comparison With Clopidogrel+Aspirin+Warfarin
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 296 participants.
Also called NCT02206815
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 296 participants
- Sponsor
- Registry
-
NCT02206815
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02206815. Randomized; no masking; primary purpose treatment. Start 2014-09-19 (actual); primary completion 2019-02-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"
- Condition
- Atrial Fibrillation
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Ticagrelor+Warfarin
- Intervention (Drug)
- Clopidogrel+Aspirin+Warfarin
- Lead sponsor
- Genshan Ma
- Collaborator
- Zhongda Hospital
Record details
- Record id
cardio:ct-nct02206815- Content hash
f9c580782793539518207d32bfb1fc8fe41785d818b883128c4b821fab4f632d